Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Origin Therapeutics Holdings, Inc. ( (TSE:SPLY) ) has shared an update.
Safe Supply Streaming Co Ltd. said its NIRLAB NIRLIGHT spectroscopy drug analysis devices are now deployed with Canadian government stakeholders and undergoing active field evaluation. The move advances the company’s push for institutional adoption of its real-time, portable drug-checking technology in public health and safety settings.
The company also reported the sale of two additional NIRLIGHT devices to a First Nations group, adding to growing uptake in Indigenous communities facing limited access to laboratory testing. Management framed both the government pilot and community sales as key milestones in establishing Safe Supply as a credible technology partner in frontline drug response and public safety across remote and urban jurisdictions.
More about Origin Therapeutics Holdings, Inc.
Safe Supply Streaming Co Ltd. is a publicly traded company focused on innovations in healthcare, wellness, and emerging technologies. Through acquisitions, partnerships, and growth capital, it builds a diversified portfolio that leverages data, science, and digital platforms to improve access and outcomes at scale.
Average Trading Volume: 176,391
Technical Sentiment Signal: Sell
Current Market Cap: C$5.92M
Find detailed analytics on SPLY stock on TipRanks’ Stock Analysis page.